Michael Saborowski

2.9k citations

26 papers · 2.1k indexed · 2 hit papers · h-index 16

Impact in

Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- CAR-T cell therapy research
- Cancer-related Molecular Pathways
Cancer Research top 5%
- Cancer Genomics and Diagnostics

Papers in ⓘ

Oncology 13
- Pancreatic and Hepatic Oncology Research 5
- Cancer Immunotherapy and Biomarkers 3
Molecular Biology 12

Co-authors: Norman Woller (8 shared papers)Florian Kühnel (7 shared papers)Scott W. Lowe (9 shared papers)Nora Fekete-Drimusz (1 shared paper)Dmitrij Ostroumov (1 shared paper)Michael P. Manns (8 shared papers)Anna Saborowski (10 shared papers)Jyrki J. Eloranta (2 shared papers)
Journals: Cancers (2 papers)Cancer Research (2 papers)Molecular Therapy (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)Scandinavian Journal of Gastroenterology (1 paper)
Partner nations: Germany United States Switzerland

In The Last Decade

Michael Saborowski

25 papers receiving 2.0k citations

Hit Papers

align trajectories log scale

CD4 and CD8 T lymphocyte interplay in controlling tumor growth 2017 · 385 citations

Peers

Countries citing papers authored by Michael Saborowski

Since Specialization

Citations

This map shows the geographic impact of Michael Saborowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Saborowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Saborowski more than expected).

Fields of papers citing papers by Michael Saborowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Saborowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Saborowski. The network helps show where Michael Saborowski may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Saborowski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Saborowski Line = papers co-authored together Michael Saborowski links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	CD4 and CD8 T lymphocyte interplay in controlling tumor growth Cellular and Molecular Life Sciences ·Dmitrij Ostroumov, Nora Fekete-Drimusz, Michael Saborowski, Florian Kühnel, Norman Woller Hit paper breakdown →	2017	385
2	Mutant p53 Drives Pancreatic Cancer Metastasis through Cell-Autonomous PDGF Receptor β Signaling Cell ·Susann Weissmueller, Eusebio Manchado, Michael Saborowski, John P. Morris, Elvin Wagenblast, Carrie Davis, Sung‐Hwan Moon, Neil T. Pfister, Darjus F. Tschaharganeh, Thomas Kitzing, Daniela E. Aust, Elke Markert, Jianmin Wu, Sean M. Grimmond, Christian Pilarsky, Carol Prives, Andrew V. Biankin, Scott W. Lowe Hit paper breakdown →	2014	362
3	Surface-enhanced resonance Raman scattering nanostars for high-precision cancer imaging Science Translational Medicine ·Stefan Harmsen, Ruimin Huang, Matthew A. Wall, Hazem Karabeber, Jason M. Samii, Massimiliano Spaliviero, Julie R. White, Sébastien Monette, Rachael O’Connor, Kenneth L. Pitter, Stephen A. Sastra, Michael Saborowski, Eric C. Holland, Samuel Singer, Kenneth P. Olive, Scott W. Lowe, Ronald G. Blasberg, Moritz F. Kircher	2015	240
4	Disruption of CRAF-Mediated MEK Activation Is Required for Effective MEK Inhibition in KRAS Mutant Tumors Cancer Cell ·Piro Lito, Anna Saborowski, Jingyin Yue, Martha Solomon, Eric W. Joseph, Sunyana Gadal, Michael Saborowski, Edward R. Kastenhuber, Christof Fellmann, Kazuhiro Ohara, Kenji Morikami, Takaaki Miura, Christine Lukacs, Nobuya Ishii, Scott W. Lowe, Neal Rosen	2014	222
5	Viral Infection of Tumors Overcomes Resistance to PD-1-immunotherapy by Broadening Neoantigenome-directed T-cell Responses Molecular Therapy ·Norman Woller, Engin Gürlevik, Bettina Fleischmann-Mundt, Anja Schumacher, Sarah Knocke, Arnold Kloos, Michael Saborowski, Robert Geffers, Michael P. Manns, Thomas Wirth, Stefan Kubicka, Florian Kühnel	2015	162
6	Optimizing sparse sequencing of single cells for highly multiplex copy number profiling Genome Research ·Timour Baslan, Jude Kendall, Brian Ward, Hilary Cox, Anthony Leotta, Linda Rodgers, M Riggs, Sean D'Italia, Guoli Sun, Yong Mao, Kristy Miskimen, Hannah Gilmore, Michael Saborowski, Nevenka Dimitrova, Alexander Krasnitz, Lyndsay N. Harris, Michael Wigler, James Hicks	2015	86
7	The Human Organic Cation Transporter-1 Gene Is Transactivated by Hepatocyte Nuclear Factor-4α Journal of Pharmacology and Experimental Therapeutics ·Michael Saborowski, Gerd A. Kullak‐Ublick, Jyrki J. Eloranta	2006	68
8	The Human Organic Anion Transporter 2 Gene Is Transactivated by Hepatocyte Nuclear Factor-4α and Suppressed by Bile Acids Molecular Pharmacology ·Katrin Popowski, Jyrki J. Eloranta, Michael Saborowski, Michael G. Fried, Peter J. Meier, Gerd A. Kullak‐Ublick	2005	66
9	Conditional Reverse Tet-Transactivator Mouse Strains for the Efficient Induction of TRE-Regulated Transgenes in Mice PLoS ONE ·Lukas E. Dow, Zeina Nasr, Michael Saborowski, Saya H. Ebbesen, Eusebio Manchado, Nilgun Tasdemir, Teresa Lee, Jerry Pelletier, Scott W. Lowe	2014	62
10	Mouse model of intrahepatic cholangiocarcinoma validates FIG–ROS as a potent fusion oncogene and therapeutic target Proceedings of the National Academy of Sciences ·Anna Saborowski, Michael Saborowski, Monika A. Davare, Brian Druker, David S. Klimstra, Scott W. Lowe	2013	62
11	Antitumoral Immune Response by Recruitment and Expansion of Dendritic Cells in Tumors Infected with Telomerase-Dependent Oncolytic Viruses Cancer Research ·Ramakrishna Edukulla, Norman Woller, Bettina Mundt, Sarah Knocke, Engin Gürlevik, Michael Saborowski, Nisar P. Malek, Michael P. Manns, Thomas Wirth, Florian Kühnel, Stefan Kubicka	2009	60
12	Tailored Tumor Immunogenicity Reveals Regulation of CD4 and CD8 T Cell Responses against Cancer Cell Reports ·Sarah Knocke, Bettina Fleischmann-Mundt, Michael Saborowski, Michael P. Manns, Florian Kühnel, Thomas Wirth, Norman Woller	2016	59
13	A modular and flexible ESC-based mouse model of pancreatic cancer Genes & Development ·Michael Saborowski, Anna Saborowski, John P. Morris, Benedikt Bosbach, Lukas E. Dow, Jerry Pelletier, David S. Klimstra, Scott W. Lowe	2014	52
14	Lipid-lowering therapy with PCSK9-inhibitors in the management of cardiovascular high-risk patients: Effectiveness, therapy adherence and safety in a real world cohort Cardiology Journal ·Michael Saborowski, Michael Dölle, Michael P. Manns, Holger Leitolf, Steffen Zender	2017	35
15	Murine Liver Organoids as a Genetically Flexible System to Study Liver Cancer In Vivo and In Vitro Hepatology Communications ·Anna Saborowski, Katharina Wolff, Steffi Spielberg, Benedikt N. Beer, Björn Hartleben, Zulrahman Erlangga, Diana Becker, Lukas E. Dow, Silke Marhenke, Norman Woller, Kristian Unger, Peter Schirmacher, Michael P. Manns, Jens U. Marquardt, Arndt Vogel, Michael Saborowski	2019	34
16	Arid1a restrains Kras-dependent changes in acinar cell identity eLife ·Geulah Livshits, Direna Alonso‐Curbelo, John P. Morris, Richard P. Koche, Michael Saborowski, John E. Wilkinson, Scott W. Lowe	2018	33
17	Clinical characteristics of patients with liver cirrhosis and spontaneous portosystemic shunts detected by ultrasound in a tertiary care and transplantation centre Scandinavian Journal of Gastroenterology ·Michael J. Lipinski, Michael Saborowski, Benjamin Heidrich, Dina Attia, Philipp Kasten, Michael P. Manns, M Gebel, Andrej Potthoff	2018	15
18	The Co‐mutational Spectrum Determines the Therapeutic Response in Murine FGFR2 Fusion‐Driven Cholangiocarcinoma Hepatology ·Gajanan Kendre, Silke Marhenke, Georgina Lorz, Diana Becker, Tanja Reineke‐Plaaß, Tanja Poth, Karthikeyan Murugesan, Florian Kühnel, Norman Woller, Ralph M. Wirtz, Andreas Pich, Jens U. Marquardt, Michael Saborowski, Arndt Vogel, Anna Saborowski	2021	14
19	Potent Antitumor Activity of Liposomal Irinotecan in an Organoid- and CRISPR-Cas9-Based Murine Model of Gallbladder Cancer Cancers ·Zulrahman Erlangga, Katharina Wolff, Tanja Poth, Alexander Peltzer, Sven Nahnsen, Steffi Spielberg, Kai Timrott, Norman Woller, Florian Kühnel, Michael P. Manns, Anna Saborowski, Arndt Vogel, Michael Saborowski	2019	14
20	Generation of focal mutations and large genomic deletions in the pancreas using inducible in vivo genome editing Carcinogenesis ·Amrendra Mishra, Fatemeh Emamgholi, Zulrahman Erlangga, Björn Hartleben, Kristian Unger, Katharina Wolff, Ulrike Teichmann, Michael Kessel, Norman Woller, Florian Kühnel, Lukas E. Dow, Michael P. Manns, Arndt Vogel, Scott W. Lowe, Anna Saborowski, Michael Saborowski	2019	9

About Michael Saborowski

Michael Saborowski is a scholar working on Oncology, Molecular Biology, Surgery, Cancer Research and Immunology, having authored 26 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Pancreatic and Hepatic Oncology Research (5 papers), Cancer Genomics and Diagnostics (4 papers), Immune Cell Function and Interaction (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Immunotherapy and Immune Responses (3 papers), MicroRNA in disease regulation (2 papers) and Pancreatic function and diabetes (2 papers). The work is most often cited by research in Oncology (1.1k citations), Cancer Research (362 citations), Immunology (378 citations), Molecular Biology (968 citations) and Biophysics (75 citations). Michael Saborowski has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Norman Woller, Florian Kühnel, Scott W. Lowe, Nora Fekete-Drimusz, Dmitrij Ostroumov, Michael P. Manns, Anna Saborowski, Jyrki J. Eloranta, Gerd A. Kullak‐Ublick and John P. Morris. Their work appears in journals such as Cancers, Cancer Research, Molecular Therapy, Journal of Pharmacology and Experimental Therapeutics and Scandinavian Journal of Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact